PT97176A - Processo para a preparacao de complexos de piroxicam/ciclodextrina e de composicoes farmaceuticas - Google Patents

Processo para a preparacao de complexos de piroxicam/ciclodextrina e de composicoes farmaceuticas

Info

Publication number
PT97176A
PT97176A PT97176A PT9717691A PT97176A PT 97176 A PT97176 A PT 97176A PT 97176 A PT97176 A PT 97176A PT 9717691 A PT9717691 A PT 9717691A PT 97176 A PT97176 A PT 97176A
Authority
PT
Portugal
Prior art keywords
piroxicam
pharmaceutical compositions
preparation
cyclodextrin complexes
complexes
Prior art date
Application number
PT97176A
Other languages
English (en)
Other versions
PT97176B (pt
Inventor
Paolo Chiesi
Fabio Carli
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of PT97176A publication Critical patent/PT97176A/pt
Publication of PT97176B publication Critical patent/PT97176B/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Pain & Pain Management (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT97176A 1990-03-27 1991-03-27 Processo para a preparacao de complexos de piroxicam/ciclodextrina e de composicoes farmaceuticas PT97176B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19829A IT1241088B (it) 1990-03-27 1990-03-27 Procedimento per la preparazione di complessi piroxicam/ciclodestrina,prodotti ottenuti e loro composizioni farmaceutiche

Publications (2)

Publication Number Publication Date
PT97176A true PT97176A (pt) 1991-11-29
PT97176B PT97176B (pt) 1998-07-31

Family

ID=11161628

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97176A PT97176B (pt) 1990-03-27 1991-03-27 Processo para a preparacao de complexos de piroxicam/ciclodextrina e de composicoes farmaceuticas

Country Status (24)

Country Link
US (1) US5164380A (pt)
EP (1) EP0449167B1 (pt)
JP (1) JPH04221314A (pt)
KR (1) KR0175934B1 (pt)
AT (1) ATE157883T1 (pt)
AU (1) AU644417B2 (pt)
CA (1) CA2039052C (pt)
CZ (1) CZ280164B6 (pt)
DE (1) DE69127566T2 (pt)
DK (1) DK0449167T3 (pt)
ES (1) ES2107430T3 (pt)
FI (1) FI102461B (pt)
GR (1) GR3025305T3 (pt)
HU (1) HU217834B (pt)
IE (1) IE910969A1 (pt)
IL (1) IL97693A (pt)
IT (1) IT1241088B (pt)
MA (1) MA22089A1 (pt)
NO (1) NO178456C (pt)
NZ (1) NZ237583A (pt)
PT (1) PT97176B (pt)
RU (1) RU2034544C1 (pt)
SK (1) SK279171B6 (pt)
ZA (1) ZA912282B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254541A (en) * 1991-11-15 1993-10-19 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indole/cyclodextrin complex
IL111184A (en) * 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
US7255877B2 (en) 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
IT1295289B1 (it) * 1997-10-07 1999-05-04 Telos S R L Co-macinati per uso cosmetico e dermatologico
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
EP1079808B1 (en) 1998-05-29 2004-02-11 Skyepharma Canada Inc. Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
US7939105B2 (en) * 1998-11-20 2011-05-10 Jagotec Ag Process for preparing a rapidly dispersing solid drug dosage form
US20060073188A1 (en) * 1999-03-31 2006-04-06 Pierre Fabre Medicament Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same
ITMI20012749A1 (it) * 2001-12-21 2003-06-21 Chiesi Farma Spa Procedimento per la preparazione mediante trattamento con microonde di composti di inclusione tra farmaco e ciclodestrine e prodotti ottenut
FR2868315B1 (fr) * 2004-04-01 2006-07-14 Pierre Fabre Medicament Sa Procede de preparation d'un compose d'inclusion soluble de substances actives dans une molecule hote avec l'aide d'un agent d'interaction par fluide supercritique
ES2424235T3 (es) 2004-04-01 2013-09-30 Pierre Fabre Medicament Complejos de inclusiones que comprenden piroxicam, una ciclodextrina y arginina
US8715731B2 (en) * 2006-03-22 2014-05-06 Isp Investments Inc. Process of reducing the bitter taste of water soluble actives by co-grinding the active with β cyclodextrin
JP5552400B2 (ja) * 2010-09-07 2014-07-16 東亜薬品株式会社 生薬類の苦味・不快味をマスキングした顆粒剤、及び口腔内速崩壊錠
CN102008450B (zh) * 2010-12-10 2013-01-30 杭州艾瑞莎生物医药科技有限公司 一种药物-环糊精纳米颗粒及其制备方法
ITMI20120092A1 (it) 2012-01-26 2013-07-27 Micro Macinazione S A Compositi di inclusione farmaco-carrier preparati con processo di attivazione meccano-chimica mediante mulini a getto di fluido ad alta energia
ITUB20161027A1 (it) * 2016-02-24 2017-08-24 Altergon Sa Preparazioni farmaceutiche oromucosali ad elevata biodisponibilita’ a base di ciclodestrina e sucralosio
US10532102B2 (en) 2016-08-19 2020-01-14 Foresee Pharmaceuticals Co., Ltd. Pharmaceutical composition and methods of uses
KR102337124B1 (ko) * 2021-05-13 2021-12-10 (주)바이오제닉스 탈모 개선용 복합 파우더 및 이를 포함하는 모발용 화장료 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
JPS6165805A (ja) * 1984-09-10 1986-04-04 Nippon Ekishiyou Kk 防殺虫フイルムの製造方法
US4579846A (en) * 1984-10-11 1986-04-01 Pfizer Inc. Antiinflammatory compositions and methods
US4672061A (en) * 1985-01-28 1987-06-09 Pfizer Inc. Antiinflammatory compositions and methods
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US4888343A (en) * 1986-09-15 1989-12-19 Bristol-Myers Company Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
US5081118A (en) * 1987-10-26 1992-01-14 Pfizer Inc. Benzothiazine dioxide derivatives
US5068226A (en) * 1987-12-07 1991-11-26 Cyclex, Inc. Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies
IT1216686B (it) * 1988-04-01 1990-03-08 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
CA1321192C (en) * 1988-04-20 1993-08-10 Abdul Majid Inclusion complexes of cyclodextrins by agglomeration
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione

Also Published As

Publication number Publication date
HU911016D0 (en) 1991-10-28
PT97176B (pt) 1998-07-31
CA2039052C (en) 2002-07-30
GR3025305T3 (en) 1998-02-27
FI102461B1 (fi) 1998-12-15
NZ237583A (en) 1992-08-26
IT9019829A1 (it) 1991-09-27
ATE157883T1 (de) 1997-09-15
KR0175934B1 (ko) 1999-03-20
AU7383891A (en) 1991-10-03
KR910016333A (ko) 1991-11-05
EP0449167A1 (en) 1991-10-02
IT1241088B (it) 1993-12-29
EP0449167B1 (en) 1997-09-10
MA22089A1 (fr) 1991-10-01
HU217834B (hu) 2000-04-28
JPH04221314A (ja) 1992-08-11
ES2107430T3 (es) 1997-12-01
DE69127566D1 (de) 1997-10-16
CA2039052A1 (en) 1991-09-28
NO178456B (no) 1995-12-27
IE910969A1 (en) 1991-10-09
NO911216D0 (no) 1991-03-25
SK279171B6 (sk) 1998-07-08
NO178456C (no) 1996-04-03
IL97693A0 (en) 1992-06-21
FI911448A (fi) 1991-09-28
NO911216L (no) 1991-09-30
DE69127566T2 (de) 1998-02-12
US5164380A (en) 1992-11-17
FI911448A0 (fi) 1991-03-26
FI102461B (fi) 1998-12-15
ZA912282B (en) 1991-12-24
HUT60738A (en) 1992-10-28
DK0449167T3 (da) 1998-03-09
IT9019829A0 (it) 1990-03-27
CZ280164B6 (cs) 1995-11-15
IL97693A (en) 1995-03-30
RU2034544C1 (ru) 1995-05-10
CS9100833A2 (en) 1991-10-15
AU644417B2 (en) 1993-12-09

Similar Documents

Publication Publication Date Title
PT97176A (pt) Processo para a preparacao de complexos de piroxicam/ciclodextrina e de composicoes farmaceuticas
ATE144523T1 (de) Glykosylierte arzneimittel-vorstufen, verfahren zu ihrer herstellung und ihre verwendungen
HUT55245A (en) Star-polymere-con jugate and process for producing them
CA2162716A1 (en) Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, its preparation and use
FI102462B1 (fi) Menetelmä nimesulidin syklodekstriinikompleksin valmistamiseksi
IT1241673B (it) Complessi di inclusione di silibinina con ciclodestrina, loro preparazione e composizioni farmaceutiche che li contengono.
DE69010307D1 (de) Fetthydrolyseverfahren.
ES474680A1 (es) Un procedimiento para la preparacion de bases colorantes de las series nigrosina e indulina
ES2036504A6 (es) Procedimiento para preparar complejos de ciclodextrina.
IT7923039A0 (it) Derivati del benzossatiolo quali fitofarmaci, processo per la loro preparazione e composizioni che licontengono.
AU665546B2 (en) Conjugates for treating gastrointestinal tumours
ES242657U (es) Dispositivo de triple cierre.
IT8619969A0 (it) Derivati del ferro, procedimento per la loro produzione e relative composizioni farmaceutiche

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910724

FG3A Patent granted, date of granting

Effective date: 19980421